Miroculus Partners with Element Biosciences to Validate the Miro Canvas Digital Microfluidics Platform for the AVITI™ System

SAN FRANCISCO–(BUSINESS WIRE)–Miroculus, Inc., developer of revolutionary tools for personal lab automation, today announced its partnership with Element Biosciences, Inc., developer of the AVITI System, a new and disruptive DNA sequencing platform launched on March 14th, to demonstrate seamless library preparation compatibility of the Miro Canvas digital microfluidics platform with the AVITI System. As technologies … [Read more…]

Seres Therapeutics Presents Microbiome Therapeutic Research at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

– Preclinical data suggest efficacy of new investigational microbial consortium, called DE486, to reduce chemotherapy-induced mucositis inflammation – – A Phase 1b clinical trial to assess whether SER-155 prevents life-threatening complications of stem cell transplant – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, announced the presentation of preclinical data supporting … [Read more…]

WellAir Appoints New CFO JJ Littrell

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–WellAir, a leading indoor air disinfection and purification solutions provider, today announced that JJ Littrell has been appointed as the Company’s Chief Financial Officer (CFO), effective immediately. Ms. Littrell has been working closely with the chief executive officer, Kari Dixon, as vice president of accounting, driving rigor and lean management across … [Read more…]

Bicycle Therapeutics to Participate in the Jefferies Healthcare Conference

CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that management will participate in a fireside chat at the Jefferies Healthcare Conference in New York, NY on Wednesday, June 8, 2022 at 8:00 a.m. … [Read more…]

Genomic Testing Cooperative to Reveal “Liquid Trace™” at ASCO, a Liquid Biopsy Test that Combines Cell-Free DNA with Targeted Transcriptome, and to Present Data on its Advanced AI for the Diagnosis of Hematologic and Solid Tumors

IRVINE, Calif.–(BUSINESS WIRE)–Genomic Testing Cooperative, LCA (GTC) announced that it will be presenting at the American Society of Clinical Oncology (ASCO) 2022 annual meeting data showcasing its new innovative approach to liquid biopsy testing that combines both cell-free-DNA (cfDNA) with cell-free RNA (cfRNA), Liquid Trace™. Liquid Trace tests both cfDNA and cfRNA not only improves … [Read more…]

Biodesix to Present at the 42nd Annual William Blair Growth Stock Conference

BOULDER, Colo.–(BUSINESS WIRE)–Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will present at the 42nd Annual William Blair Growth Stock Conference being held June 6-9, 2022 at the Lowes Chicago Hotel in Chicago, IL. 42nd Annual William Blair … [Read more…]

Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce that U.S. EPA has Added Nanocyn® Hospital-Grade Disinfectant to List N for Use Against COVID-19

WOODSTOCK, Ga.–(BUSINESS WIRE)–Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions and disinfectant use, and its partner, the MicroSafe Group DMCC, are pleased to announce that Nanocyn® hospital grade … [Read more…]

CareMax, Inc. to Acquire Medicare Value-Based Care Business of Steward Health Care System

Transaction to expand CareMax’s comprehensive and coordinated healthcare delivery system designed to improve overall health outcomes for senior value-based care patients Brings CareMax’s high-quality, whole person healthcare to underserved communities with a focus on patients’ social determinants of health to promote health equity Initially adds approximately 170,000 senior value-based care patients across eight states Transaction … [Read more…]

Prince Edward Island Becomes a National Leader in Providing Coverage for Dexcom G6 Continuous Glucose Monitoring System for Canadians With Diabetes

With CGM now part of the Diabetes Canada Clinical Practice Guidelines, Dexcom CGM use is proven to improve glycemic control1,2 and can reduce the risk of costly long-term diabetes-related complications compared to fingerstick monitoring.3 BURNABY, British Columbia–(BUSINESS WIRE)–Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (rtCGM), announced today that people with … [Read more…]

Global Tissue Diagnostic Market Report 2022: Increasing Number of Clinical Trials Pertaining to Cancer Drugs – Industry Analysis, Trends, Market Size, and Forecasts 2021-2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Tissue Diagnostic Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027” report has been added to ResearchAndMarkets.com’s offering. The report predicts the global tissue diagnostic market to grow with a CAGR of 7.14% over the forecast period from 2021-2027. The report on the global tissue diagnostic market provides qualitative and … [Read more…]